Top Markets
Coin of the day
Lite Strategy, Inc. Lite Strategy, Inc.

Lite Strategy, Inc.

LITS
株式のランク #27541
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
株価
$0.9474
最終同期: 2026-08-19
時価総額
$32.24M
変化(1日)
7.41%
変化(1年)
-
US
取引 Lite Strategy, Inc. (LITS)

カテゴリー

Lite Strategy, Inc.(LITS)の配当利回りの履歴
Lite Strategy, Inc.(銘柄コード: LITS)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Lite Strategy, Inc.(LITS)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)